FDA clears UCLA heart tissue regeneration drug for clinical trials
Funded entirely by taxpayer dollars, this first-of-its-kind drug, AD-NP1, targets cellular metabolism to promote tissue repair of multiple organs
UCLA scientist receives $2.3 million grant from California’s stem cell agency to advance novel stem cell-based treatments for leukemia in Down syndrome
Adapted from an article published today by UCLA Broad Stem Cell Research Center By Linda Wang Hanna Mikkola, professor of
Headspace invaders: How mosquito-borne viruses breach the brain’s defenses
By Tiare Dunlap Originally published by Broad Stem Cell Research Center Key Takeaways Mosquito-borne viruses can cause more than fevers
Professor Amy Rowat receives 2025 Gold Shield Faculty Prize
By Wendy Soderberg This article was originally published by UCLA Health When Amy Rowat — a UCLA professor in the department of
Dr. Hanna Mikkola receives $1M grant to develop safer treatments for myeloid leukemia of Down syndrome
By Denise Heady This story was originally published by UCLA Health Dr. Hanna Mikkola, professor of molecular, cell and developmental biology
